Menopausal metabolic syndrome and obesity

Abstract

In this review, it is presented the importance for metabolic processes of decreasing estradiol concentration in connection with prolapsus of ovary function in women. Here, influence of different modes of substitute hormonal therapy, of different progestagenic components included in preparations is discussed.

Keywords

obesity / menopausal metabolic syndrome / estradiol / substitute hormonal therapy

References

[1] Репина М.А. Подходы к профилактике сосудистых нарушений у женщин в пери- постменопаузе // Проблемы репродукции. - 1996. - № 3. - С. 55-59.

[2] Репина М.А., Зинина Т.А., Корзо Т.М. Фемостон как препарат для ЗГТ при выпадении функции яичников // Журнал акушерства и женских болезней. - 1999. -№ 1. - 94-101.

[3] Шестакова И.Г. Влияние комбинированной ЗГТ 17b- эстрадиолом с дидрогестероном на углеводный обмен, массу тела и распределение жировой ткани у женщин в постменопаузе // Климактерий и постменопауза. — 1999. - № 4. - 13-15.

[4] Шестакова И.Г. Клинические особенности менопаузального метаболического синдрома // Тез. докл. 1-го Российского конгресса по менопаузе. Климактерий. - 2001. - № 3. - 18-18.

[5] Шестакова И.Г., Сметник В.П. Эффективность различных режимов ЗГТ при менопаузальном метаболическом синдроме. Там же, 18-18.

[6] Ala-Fossi S.L., Маеnраа J., Aine R., Риппопеп R. Ovarian testosterone secretion during perimenopause // Maturitas. - 1998,29. - C. 239-245.

[7] Albers G., Taggart H., Applebaum-Bowden D. et al. Reduktion of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp/a/lipoprotein with the anabolik steroid stanozol // Biochim. Biophys. Acta. - 1984, 795. - P. 293-296.

[8] Aloia J.F., Vaswani A., Russo L. et al. The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass // American Journal of Obstetrics and Gynecology. - 1995,172. - P. 896-900.

[9] Buch T., Barrett-Connor E., Cowan L. et al. Cardiovascular mortality and noncontraceptive use of estrogen in women // Circulation. - 1987, 75. - P. 1102-1109.

[10] Cagnacci A., Soldani R., Carriero P. et al. Effects of low doses of transdermal 17b-estradiol on carbohydrate metabolism in postmenopausal women // J. Clin. Endocrin. Metab. - 1992, 74. - P. 1396-1400.

[11] Chmouliovsky L., Habicht F., James R.W. et al. Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women // Maturitas. - 1999, 32. -P. 147-153.

[12] O'Connor K.G., Harman S.M., Stevens T.E. et al.Interrelationships of spontaneous growth hormone axis activity, body fat and serum lipids in healthy elderly women and men // Metabolism. - 1999, 48. - P. 1424-1431.

[13] Considine R., Sinha M.K., Heiman M.J. et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans // N. Engl. J. Med. - 1996, 334. - P. 292-295.

[14] Crook D., Sidhu M., Stevenson J. Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid // Atherosclerosis. - 1992, 92. - P. 41-47.

[15] Despres J.P., Marette A. Relation of components of insulin resistance syndrome to coronary disease risk // Cun. Opin. Lipidol. - 1994, 5. - P. 274-289.

[16] Douchi T., Yamamoto Sh., Nakamura S. et al. The effect of menopause on regional and total body lean mass // Maturitas. - 1998, 29. - P. 247-252.

[17] Farish E., Fletcher C., Hart D. et al. Effects of bilateral oohorectomy on lipoprotein metabolism // Br. J. Obstet, Gynaecol. - 1991, 97. - P. 78-82.

[18] Frayn K. Insulin resistance and lipid metabolism // Curr. Opin. Lipidol. - 1993, 4. - P. 197-204.

[19] Goodsland I.F., Crook D., Stevenson F. et al. Insulin resistance syndrome in postmenopausal women with cardiological syndrome // Br. Heart. J. - 1995, 74. - P. 47-52.

[20] Haarbo J., Hansen B., Christiansen C. Hormone replacement therapy prevents coronary artery disease in ovariectomized rabbits // APMIS. - 1991, 99. - 721-727.

[21] Haffner S., Katz M., Stem M. et al. The relationshipbetween sex hormones to hyperinsulinaemia and hyperglycaemia // Metabolism. - 1988, 37. - P. 683-688.

[22] Hanggi W., Lippuner K., Riesen W. et al. Long term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study // Brit. J. Obstet. Gynaecol. - 1997,104. - P. 708-717.

[23] Hanggi W., Lippunert K., Jaegert Ph. et al. Differential impact of conventional oral or transdermal hormone replacement therapy on body composition // Clin. Endocrinol. - 1998, 48. - P. 691-699.

[24] Horvath B., Turay A., Kneffel P. Increased body weight as a risk factor for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding // Maturitas. — 2000, 35. - P. 73-73.

[25] Hulley S., Grady D., Bush T. et al. Heart and Estrogen / Progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women // J. Am. Med. Assoc. - 1998, 280. - P. 605-613.

[26] Jensen J., Nilas I., Christiansen C. Influence of menopause on serum lipids and lipoproteins // Maturitas. - 1990, 12. - P. 321-331.

[27] Lobo R., Speroff L. International consensus conference on postmenopausal hormone therapy and the cardiovascular system // Fertil Steril, 1994, 62,176-179.

[28] Matalliotakis J., Panidis D., Roussos D. et al. Leptin concentrations in women with POS // Maturitas. — 2000, 35. - P. 57-58.

[29] Meilahn E., Kuller L., Matthews K.. Stein A. Lp(a) concentrations among pre- and postmenopausal women over time // Circulation. - 1991, 84. - P. 546-557.

[30] Van der Mooren J., Demacker P., Thomas C. et al. Beneficial effects on serum lipoproteins by 17b-estradiol - dehydro- gesterone therapy in postmenopausal women // Eur. J. Obstet. Gynecol. Reprod. Biol. - 1992, 47. - P. 153-160.

[31] Nabulsi A., Folsom A., White A. et al. Association of hormone - replacement therapy with various cardiovascular risk factors in postmenopausal women // New Engl. J. Med. — 1993,15. - P. 1069-1075.

[32] Nestler J. Editorial: sex hormone binding globulin: a marker for hyperinsulinaemia and / or insulin resistance? // J. Clin. Endocrinol. Metab. - 1993, 76. - P. 273-274.

[33] Panidis D., Rousso D., Kourtis A. et al. The effect of estrogens on leptin secretion // Maturitas. - 2000, 35. - P. 22-22.

[34] Phillips S.K., Rook K.M., Siddle N.C. et al. Muscle weakness in women occurs at earlier age than in men, but strength is preserved by hormone replacement therapy // Clin. Sci. - 1993, 84. - P. 95-98.

[35] Poehlman E.T., Toth M.J., Gardner A. W. Changes in energy balance and body composition at menopause: A controlled longitudinal study // Ann. Intern. Med. - 1995, 123. - P. 673-675.

[36] Reubinoff B.E., Wurtman J., Rojansky N. et al. Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study // Ferlit Steril. - 1995, 64. - P. 963-968.

[37] Rymer J., Crook D., Sidhu M. et al. Effects of tibolone on serum concentrations of lipoprotein (a) in postmenopausal women // Acta Endocrinol. - 1993,128. - P. 259-262.

[38] Samsioe G. HRT and vaginal bleeds // Zentralblatt Gynakol. - 1996,118. - P. 181-187.

[39] Schaefer E., Foster D., Zech J. et al. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females // J. Clin. Endocrinol. Metab. - 1983, 57. - P. 262-267.

[40] Seed M. Postmenopausal HRT, coronary hearts disease and plasma lipoproteins // Drugs. - 1994, 47, 2. - P. 25-34.

[41] Stevenson J., Crook D., Godsland I. et al. Oral versus transdermal hormone replacement therapy // Intern. J. Fertil. Menop. Studies. - 1993, 38. - P. 30-35.

[42] Taaffe D.R., Villa M.L., Delay R. et al. Maximal muscle strength of elderly women is not influenced by estrogen status // Age Ageing. - 1995, 24. - P. 329-333.

[43] Tikkanen M. The menopausal and hormone replacement therapy // Maturitas. - 1996, 22. - P. 209-216.

[44] Toth M.J., Tchemof A., Sites C.K. et al. Menopausal-related changes in body fat distribution // Ann. J. Acad. Sci. - 2000, 904. - P. 502-506.

[45] Walsh B., Schiff I., Rosner B. et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins // New Engl. J. Med. - 1991.325. - P. 1196-1204.

[46] Whitcroft S., Crook D., Marsh M. et al. Long-term effects of oral and transdermal HRT on serum lipid and lipoprotein concentrations // Obstet. Gynecol. - 1994, 84. - P. 222-226.

[47] Wu S., Chou P., Tsai S. et al. The impact of years since menopause on the development of impaired glucose tolerance // J. Clin Epidemiol. - 2001, 54. - P. 117-120.

[48] Zhang V., Proenca R., Maffei M. et al. Positional cloning of the mouse obese gene and its human homologue // Nature. - 1994, 372. - P. 425-432.

RIGHTS & PERMISSIONS

Eсо-Vector